Principal speaker
Professor Michael Parker
PROFESSOR MICHAEL PARKER WILL PRESENT ON:
"Seeing is believing - structural biology in drug discovery"
Deputy Director, Biota Structural Biology Laboratory, St Vincent's Institute and Professorial Fellow, Bio21 Institute, University of Melbourne.
Michael is an Australian Research Council Federation Fellow and Head of the ACRF Rational Drug Discovery Facility. He has published over 200 papers and was elected into the Australian Academy of Science in 2010.
About the CRC Cancer Therapeutics (CTx) …
Cancer Therapeutics (CTx) CRC is a recently established cancer drug development company. It works with cancer researchers to discover and develop their promising cancer targets into pre-clinical small molecule drug candidates. Core partners in CTx include CSIRO Molecular Health Technologies, Cancer Council Victoria, Walter and Eliza Hall Institute, St Vincent’s Institute, Monash University’s Institute of Pharmaceutical Sciences, Griffith University, Peter MacCallum Cancer Centre and Cancer Research Technology Ltd (UK).
Event categories
Event contact details
- Jo-Anne Sakrzewski
- http://www.cancercrc.com
- 073735 6007